Cargando…

Molecular genetics of Parkinson’s disease: Contributions and global trends

Parkinson’s disease (PD) is a neurodegenerative disorder primarily characterized by motor dysfunction. Aging is the greatest risk factor for developing PD. Recent molecular genetic studies have revealed that genetic factors, in addition to aging and environmental factors, play an important role in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funayama, Manabu, Nishioka, Kenya, Li, Yuanzhe, Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968657/ https://www.ncbi.nlm.nih.gov/pubmed/35821405 http://dx.doi.org/10.1038/s10038-022-01058-5

Ejemplares similares

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
por: Nishioka, Kenya, et al.
Publicado: (2022)

Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease
por: Daida, Kensuke, et al.
Publicado: (2020)

A complex form of hereditary spastic paraplegia harboring a novel variant, p.W1515*, in the SPG11 gene
por: Daida, Kensuke, et al.
Publicado: (2022)

Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations
por: Takanashi, Masashi, et al.
Publicado: (2018)

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
por: Tezuka, Toshiki, et al.
Publicado: (2022)

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features
por: Ikeda, Aya, et al.
Publicado: (2019)

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
por: Ogata, Jun, et al.
Publicado: (2021)

Parkinsonism Relating to Intoxication with Glyphosate
por: Eriguchi, Makoto, et al.
Publicado: (2019)

CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification
por: Daida, Kensuke, et al.
Publicado: (2017)

Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
por: Takeshige, Haruka, et al.
Publicado: (2018)

α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
por: Daida, Kensuke, et al.
Publicado: (2022)

ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout
por: Matsuo, Hirotaka, et al.
Publicado: (2015)

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
por: Yamaguchi, Akihiro, et al.
Publicado: (2020)

The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson’s disease
por: Tanaka, Ryota, et al.
Publicado: (2020)

Radiation-induced Brain Calcification Leads to L-dopa-resistant Parkinsonism and Cerebellar Ataxia
por: Shimada, Tomoyo, et al.
Publicado: (2022)

Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
por: Sato, Shigeto, et al.
Publicado: (2011)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Long-read sequencing resolves a complex structural variant in PRKN Parkinson’s disease
por: Daida, Kensuke, et al.
Publicado: (2023)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Unclassified four-repeat tauopathy associated with familial parkinsonism and progressive respiratory failure
por: Nakano, Masayoshi, et al.
Publicado: (2020)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c
por: Meng, Hongrui, et al.
Publicado: (2017)

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson’s Disease
por: Klein, Christine, et al.
Publicado: (2018)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy
por: Lin, Chin-Hsien, et al.
Publicado: (2020)

Acute transient freezing of gait in a patient with posterior reversible encephalopathy syndrome
por: Nakajima, Asuka, et al.
Publicado: (2013)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
por: Imai, Yuzuru, et al.
Publicado: (2019)

Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
por: Ogawa, Takashi, et al.
Publicado: (2018)

Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease
por: Nuermaimaiti, Maierdanjiang, et al.
Publicado: (2018)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma
por: Nishioka, Kenya, et al.
Publicado: (2017)

New-onset Refractory Status Epilepticus Involving the Limbic System, Spinal Cord, and Peripheral Nerves
por: Daida, Kensuke, et al.
Publicado: (2019)

Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia
por: Shibata, Nobuto, et al.
Publicado: (2013)

Current Topics in Deep Brain Stimulation for Parkinson Disease
por: UMEMURA, Atsushi, et al.
Publicado: (2016)

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
por: Suzuki, Ayako, et al.
Publicado: (2016)

Effects of Aging and Idiopathic Parkinson’s Disease on Tactile Temporal Order Judgment
por: Nishikawa, Natsuko, et al.
Publicado: (2015)

Motor/Nonmotor Symptoms and Progression in Patients with Parkinson's Disease: Prevalence and Risks in a Longitudinal Study
por: Yoritaka, Asako, et al.
Publicado: (2020)

Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson's Disease
por: Yoritaka, Asako, et al.
Publicado: (2022)

Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease
por: Yamashiro, Kazuo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3mcbvdqpfrgd7bl1c0umvc3g0v